Quick Takeaways
- S.H.N. Financial Investments Ltd. filed SCHEDULE 13G/A for Tenax Therapeutics, Inc. Common stock, par value $0.0001 (TENX).
- Disclosed ownership: 5%.
- Date of event: 31 Dec 2024.
S.H.N. Financial Investments Ltd. - 31 Dec 2024 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common stock, par value $0.0001 (TENX)
- Filing Manager
- S.H.N. Financial Investments Ltd.
- Reporting Manager
- S.H.N. Financial Investments Ltd.
- Symbol
- TENX
- Shares outstanding
- 3,588,176 shares
- Disclosed Ownership
- 179,050 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 18 Mar 2025, 16:12:37 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"S.H.N. Financial Investments Ltd. disclosed 5% ownership in Tenax Therapeutics, Inc. Common stock, par value $0.0001 (TENX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Mar 2025, 16:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| S.H.N. Financial Investments Ltd. | 5% | 179,050 | 179,050 | 0 | /s/ Nir Shamir | Nir Shamir, Chief Executive Officer |